These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7759013)

  • 1. [Cancer therapy--economic aspects].
    Catane R; Catane H; Rozencweig M
    Harefuah; 1995 Feb; 128(3):182-5. PubMed ID: 7759013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer and health economics].
    Koinuma N
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system].
    Perrier L; Borella L; Philip T
    Bull Cancer; 2003 Nov; 90(11):1005-9. PubMed ID: 14706905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of supportive therapy in cancer patients.
    Wolf MM
    Aust Health Rev; 1982 May; 5(2):29-31. PubMed ID: 10309736
    [No Abstract]   [Full Text] [Related]  

  • 5. [Economic aspects of the fight against cancer].
    Shubin BM; Rutgaĭzer VM; Khadzhiev MA; Aleksandrorva LA
    Sov Med; 1984; (5):64-8. PubMed ID: 6431616
    [No Abstract]   [Full Text] [Related]  

  • 6. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood progenitor cell transplantation: economic issues.
    Yee GC
    Pharmacotherapy; 1998; 18(1 Pt 2):9S-16S. PubMed ID: 9473174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formalized method of deciding on treatment options in clinical oncology].
    Chekhonadskiĭ VN; Benevskiĭ AI; Davydov MI
    Vopr Onkol; 2002; 48(6):691-4. PubMed ID: 12530265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of cancer therapy].
    Hisashige A
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1347-53. PubMed ID: 10969588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Money matters: how cost-effectiveness studies are done.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1411. PubMed ID: 15467024
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic cost analysis in cancer management and its relevance today.
    Sharma K; Das S; Mukhopadhyay A; Rath GK; Mohanti BK
    Indian J Cancer; 2009; 46(3):184-9. PubMed ID: 19574668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
    Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Introduction of information technology in the field of cancer therapy].
    Tobisu K
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):477-83. PubMed ID: 15114686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses.
    Carlson LE; Bultz BD
    Psychooncology; 2004 Dec; 13(12):837-49; discussion 850-6. PubMed ID: 15578622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A postcode lottery still exists for cancer patients with 'exceptional circumstances'.
    Clarke R; Waddell T; Gallagher J; Lee K; Radhakrishna G; Cavet J; Hawkins RE; Saunders MP
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):771-2. PubMed ID: 18973994
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
    Lyman GH; Kuderer NM
    Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.